Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the world. It is linked mainly to insulin resistance and metabolic syndrome including obesity and dyslipidemia. In addition, various endocrine dysfunctions including polycystic ovary syndrome (PCOS) and hyp...

Full description

Bibliographic Details
Main Authors: Myeong Jun Song, Jong Young Choi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1053709/full
_version_ 1811318999345004544
author Myeong Jun Song
Jong Young Choi
author_facet Myeong Jun Song
Jong Young Choi
author_sort Myeong Jun Song
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the world. It is linked mainly to insulin resistance and metabolic syndrome including obesity and dyslipidemia. In addition, various endocrine dysfunctions including polycystic ovary syndrome (PCOS) and hypogonadism are involved in the development and progression of NAFLD. We need to know the disease pathophysiology more accurately due to the heterogeneity of clinical presentation of fatty liver disease. The liver is the major metabolic organ with sexual dimorphism. Sexual dimorphism is associated not only with behavioral differences between men and women, but also with physiological differences reflected in liver metabolism. In men, normal androgen levels prevent hepatic fat accumulation, whereas androgen deficiency induce hepatic steatosis. In women, higher androgens can increase the risk of NAFLD in PCOS. Sex hormone binding globulin (SHBG) is involved in androgen regulation. Recently, SHBG may be reported as a surrogate marker for NAFLD. Therefore, this review will focus on the mechanism of androgen dysfunction in the regulation of hepatic metabolism, the risk of developing NAFLD, and the potential role of SHBG in the course of NAFLD.; Keywords: Non-alcoholic fatty liver disease, insulin resistance, sexual dimorphism, androgen, sex hormone binding globulin
first_indexed 2024-04-13T12:34:42Z
format Article
id doaj.art-95319ae70b384bce82969b859a4a380d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T12:34:42Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-95319ae70b384bce82969b859a4a380d2022-12-22T02:46:42ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.10537091053709Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulinMyeong Jun SongJong Young ChoiNon-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the world. It is linked mainly to insulin resistance and metabolic syndrome including obesity and dyslipidemia. In addition, various endocrine dysfunctions including polycystic ovary syndrome (PCOS) and hypogonadism are involved in the development and progression of NAFLD. We need to know the disease pathophysiology more accurately due to the heterogeneity of clinical presentation of fatty liver disease. The liver is the major metabolic organ with sexual dimorphism. Sexual dimorphism is associated not only with behavioral differences between men and women, but also with physiological differences reflected in liver metabolism. In men, normal androgen levels prevent hepatic fat accumulation, whereas androgen deficiency induce hepatic steatosis. In women, higher androgens can increase the risk of NAFLD in PCOS. Sex hormone binding globulin (SHBG) is involved in androgen regulation. Recently, SHBG may be reported as a surrogate marker for NAFLD. Therefore, this review will focus on the mechanism of androgen dysfunction in the regulation of hepatic metabolism, the risk of developing NAFLD, and the potential role of SHBG in the course of NAFLD.; Keywords: Non-alcoholic fatty liver disease, insulin resistance, sexual dimorphism, androgen, sex hormone binding globulinhttps://www.frontiersin.org/articles/10.3389/fendo.2022.1053709/fullnon-alcholic fatty liver diseaseinsuline resistancesexual dimorphismandrogensex hormone binding globhulin
spellingShingle Myeong Jun Song
Jong Young Choi
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Frontiers in Endocrinology
non-alcholic fatty liver disease
insuline resistance
sexual dimorphism
androgen
sex hormone binding globhulin
title Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
title_full Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
title_fullStr Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
title_full_unstemmed Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
title_short Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
title_sort androgen dysfunction in non alcoholic fatty liver disease role of sex hormone binding globulin
topic non-alcholic fatty liver disease
insuline resistance
sexual dimorphism
androgen
sex hormone binding globhulin
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1053709/full
work_keys_str_mv AT myeongjunsong androgendysfunctioninnonalcoholicfattyliverdiseaseroleofsexhormonebindingglobulin
AT jongyoungchoi androgendysfunctioninnonalcoholicfattyliverdiseaseroleofsexhormonebindingglobulin